Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

The Role of Immunotherapy in Treating R/R mHCC

July 24th 2019

REACH-2 Regimen to Treat Relapsed/Refractory mHCC

July 24th 2019

The Role of Cabozantinib as Second-Line Therapy in mHCC

July 24th 2019

Second-Line Therapy Options for mHCC

July 24th 2019

Sorafenib and Lenvatinib Adverse Events

July 24th 2019

Systemic Therapy in MHCC: Sorafenib vs Lenvatinib

July 24th 2019

Locoregional Therapy for Liver-Confined HCC

July 24th 2019

The Importance of HCC Multidisciplinary Management

July 24th 2019

Curative Intent Options in Early-Stage HCC

July 24th 2019

The Diagnostic Approach to HCC

July 24th 2019

Determining Factors in HCC Prognosis

July 24th 2019

Hepatocellular Carcinoma Overview

July 24th 2019

Any Role for Immunotherapy in Pancreatic Cancer?

July 24th 2019

Emerging Therapy for Pancreas Cancer

July 24th 2019

Metastatic Pancreas Cancer; Salvage Therapy

July 24th 2019

Metastatic Pancreas Cancer; Sequencing Therapies

July 24th 2019

POLO Trial in Pancreatic Cancer

July 24th 2019

PARP Inhibitors gBRCA1/2-Mutated Pancreatic Cancer

July 24th 2019

Schedules for Gemcitabine, Nab-Paclitaxel for Pancreatic Cancer

July 24th 2019

FOLFIRINOX-Based Regimens for Pancreatic Cancer

July 24th 2019